UK & Ireland, experts provided insights on market trends within the clinical trial industry and advice on engagement strategies.

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for ...

FibroBiologics, Inc. (Nasdaq: FBLG) ('FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures ...

Richard Pulliam, SVP and General Manager of Wolters Kluwer EHS & ESG, said: "We are committed to continuous innovation through product development and new collaborations to ensure our clients have ...

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...

CEO's personal contribution fully funds build-out and first-year operationsDoubled HQ footprint centralizes cross-functional ...

ASX health stocks fall o.92% over past five days as US President Donald Trump renews threat to impose tariffs on pharmaceutical imports.

Hospital and health system executives facing potential effects of the One Big Beautiful Bill Act, workforce gaps and operational challenges are preparing strategies for staying ahead in an evolving ...

Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders ...

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers ...

Tata Consultancy Services Ltd., Hindustan Unilever Ltd., Bharat Forge Ltd., and Glenmark Pharma Ltd. were among the top ...

Painreform Ltd (NASDAQ:PRFX) shares declined 11% following the company’s announcement of a strategic investment deal with LayerBio Inc., a private biotech firm based in Boston. Under the terms, ...